While members of his cabinet stuff sauerkraut down their wives’ handbags to maintain diets, speculation is suddenly mounting over whether President Donald Trump may have received early access to retatrutide, the potent experimental weight-loss drug from Eli Lilly eagerly anticipated by millions.

The questions come amid a new report in STAT News pointing to a certain 79-year-old man with special insider connections who somehow managed to gain access to retatrutide, which has not received FDA approval, through the agency’s “compassionate use”........

© Mother Jones